Combination of cyclosporine and leflunomide versus single therapy in severe rheumatoid arthritis

Journal of Rheumatology

Volumn 33, Issue 3, 2006, Pages 486-489

  Karanikolas, George ^a   Charalambopoulos, Dionisios ^a   Andrianakos, Alexandros ^a   Antoniades, Christos ^a   Katsilambros, Nikolaos ^a  

^a NONE

Author keywords

Combination Therapy; Cyclosporine; Leflunomide; Rheumatoid arthritis

Indexed keywords

CREATINE; CYCLOSPORIN A; DISEASE MODIFYING ANTIRHEUMATIC DRUG; GAMMA GLUTAMYLTRANSFERASE; LEFLUNOMIDE; PREDNISOLONE;

ALOPECIA; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIARRHEA; DISEASE ACTIVITY; DISEASE SEVERITY; DRUG EFFICACY; DRUG SAFETY; DRUG WITHDRAWAL; ERYTHEMA MULTIFORME; FEMALE; GINGIVA HYPERPLASIA; HEADACHE; HERPES ZOSTER; HIRSUTISM; HUMAN; HYPERTENSION; KIDNEY DYSFUNCTION; LIVER DYSFUNCTION; MAJOR CLINICAL STUDY; MONOTHERAPY; MOUTH ULCER; MULTICENTER STUDY; NAUSEA; PARESTHESIA; PRIORITY JOURNAL; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; RASH; RHEUMATOID ARTHRITIS; SCORING SYSTEM; SIDE EFFECT; TREATMENT OUTCOME; UPPER RESPIRATORY TRACT INFECTION; WEIGHT REDUCTION;

ADJUVANTS, IMMUNOLOGIC; AGED; ANTIRHEUMATIC AGENTS; ARTHRITIS, RHEUMATOID; CYCLOSPORINE; DRUG THERAPY, COMBINATION; FEMALE; HUMANS; ISOXAZOLES; JOINTS; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME;

EID: 33644686282     PISSN: 0315162X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (14)

1. Andrianakos A, Trontzas P, Christoyannis F, et al. Prevalence of rheumatic diseases in Greece: a cross-sectional population based epidemiological study. The ESORDIG Study. J Rheumatol 2003;30:1589-601.
2. Felson DT, Anderson JJ, Boers M, et al. The American College of Rheumatology preliminary definition of improvement in rheumatoid arthritis. Arthritis Rheum 1995;38:727-35.
3. van Gestel AM, Haagsma CJ, van Riel PL. Validation of rheumatoid arthritis improvement criteria that include simplified joint counts. Arthritis Rheum 1998;41:1845-50.
4. Heydendael V, Spuls P, Opmeer B, et al. Methotrexate versus cyclosporine in moderate-to-severe chronic plaque psoriasis. N Engl J Med 2003;349:658-65.
5. Papadopoulos N, Alamanos Y, Papadopoulos I, Tsifetaki N, Voulgari P, Drosos A. Disease modifying antirheumatic drugs in early rheumatoid arthritis: a long term observational study. J Rheumatol 2002;29:261-6.
6. Kalden JR, Schattenkirchner M, Sorensen H, et al. The efficacy and safety of leflunomide in patients with active rheumatoid arthritis: a five-year followup study. Arthritis Rheum 2003;48:1513-20.
7. Verhoeven AC, Boers M, Tugwell P. Combination therapy in rheumatoid arthritis: updated systematic review. Br J Rheumatol 1998;37:612-9.
8. Hochberg MC, Tracy JK, Flores RH. "Stepping up" from methotrexate: a systematic review of randomized placebo controlled trials in patients with rheumatoid arthritis with an incomplete response to methotrexate. Ann Rheum Dis 2001;60 Suppl 3:iii51-4.
9. Maini R, St. Clair EW, Breedveld F, et al. Infliximab (chimeric anti-tumour necrosis factor alpha monoclonal antibody) versus placebo in rheumatoid arthritis patients receiving concomitant methotrexate: a randomised phase III trial. ATTRACT Study Group. Lancet 1999;354:1932-9.
10. Weinblatt ME, Kremer JM, Bankhurst AD, et al. A trial of etanercept, a recombinant tumor necrosis factor receptor: Fc fusion protein, in patients with rheumatoid arthritis receiving methotrexate. N Engl J Med 1999;340:253-9.
11. Weinblatt ME, Keystone EC, Furst DE, et al. Adalimumab, a fully human anti-tumor necrosis factor alpha monoclonal antibody, for the treatment of rheumatoid arthritis in patients taking concomitant methotrexate: the ARMADA trial. Arthritis Rheum 2003;48:35-45.
12. Cohen S, Hurd E, Cush J, et al. Treatment of rheumatoid arthritis with anakinra, a recombinant human interleukin-1 receptor antagonist, in combination with methotrexate: results of a twenty-four-week, multicenter, randomized, double-blind, placebo-controlled trial. Arthritis Rheum 2002;46:614-24.
13. Keane J, Gershon S, Wise RP, et al. Tuberculosis associated with infliximab, a tumor necrosis factor-alpha neutralizing agent. N Engl J Med 2001;345:1098-104.
14. Wolfe F, Michaud K. Lymphoma in rheumatoid arthritis: the effect of methotrexate and anti-tumor necrosis factor therapy in 18,572 patients. Arthritis Rheum 2004;50:1740-51.